Anthraquinone-fused enediynes (AQEs)
are renowned for their distinctive
molecular architecture, reactive enediyne warhead, and potent anticancer
activity. Although the first members of AQEs, i.e., dynemicins, were
discovered three decades ago, how their nitrogen-containing carbon
skeleton is synthesized by microbial producers remains largely a mystery.
In this study, we showed that the recently discovered sungeidine pathway
is a “degenerative” AQE pathway that contains upstream
enzymes for AQE biosynthesis. Retrofitting the sungeidine pathway
with genes from the dynemicin pathway not only restored the biosynthesis
of the AQE skeleton but also produced a series of novel compounds
likely as the cycloaromatized derivatives of chemically unstable biosynthetic
intermediates. The results suggest a cascade of highly surprising
biosynthetic steps leading to the formation of the anthraquinone moiety,
the hallmark C8–C9 linkage via alkyl–aryl cross-coupling,
and the characteristic epoxide functionality. The findings provide
unprecedented insights into the biosynthesis of AQEs and pave the
way for examining these intriguing biosynthetic enzymes.